Skip to content
10-Q

Quarterly Report

INHIBRX BIOSCIENCES, INC. INBX

0002007919-25-000081

← back to feed
Filed
Aug 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 8, 2025 14.49M sh
Shares Diluted Q2 2025 · Jun 30, 2025 15.47M sh
Shares Diluted Q2 2025 · Jun 30, 2025 15.47M sh
Shares Diluted Q2 2025 · Jun 30, 2024 14.81M sh
Shares Diluted Q2 2025 · Jun 30, 2024 14.5M sh
Capex Q2 2025 · Jun 30, 2025 $21K
Capex Q2 2025 · Jun 30, 2024 $2.33M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$65.85M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$120.41M
Long Term Debt Q2 2025 · Jun 30, 2025 $99.28M
Long Term Debt Q2 2025 · Dec 31, 2024 $0
Cash And Equivalents Q2 2025 · Jun 30, 2025 $186.57M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $152.6M
Stockholders Equity Q2 2025 · Jun 30, 2025 $68.56M
Stockholders Equity Q2 2025 · Mar 31, 2025 $94.44M
Stockholders Equity Q2 2025 · Dec 31, 2024 $133.58M
Stockholders Equity Q2 2025 · Jun 30, 2024 $219.37M
Stockholders Equity Q2 2025 · Mar 31, 2024 $11.57M
Stockholders Equity Q2 2025 · Dec 31, 2023 $43.5M
Current Liabilities Q2 2025 · Jun 30, 2025 $38.94M
Current Liabilities Q2 2025 · Dec 31, 2024 $40.73M
Total Liabilities Q2 2025 · Jun 30, 2025 $143.56M
Total Liabilities Q2 2025 · Dec 31, 2024 $47.18M
Current Assets Q2 2025 · Jun 30, 2025 $193.96M
Current Assets Q2 2025 · Dec 31, 2024 $160.4M
Total Assets Q2 2025 · Jun 30, 2025 $212.12M
Total Assets Q2 2025 · Dec 31, 2024 $180.77M
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.85
Eps Diluted Q2 2025 · Jun 30, 2025 −$4.65
Eps Diluted Q2 2025 · Jun 30, 2024 $125.48
Eps Diluted Q2 2025 · Jun 30, 2024 $122.75
Eps Basic Q2 2025 · Jun 30, 2025 −$1.85
Eps Basic Q2 2025 · Jun 30, 2025 −$4.65
Eps Basic Q2 2025 · Jun 30, 2024 $127.10
Eps Basic Q2 2025 · Jun 30, 2024 $125.93
Sga Expense Q2 2025 · Jun 30, 2025 $6.42M
Sga Expense Q2 2025 · Jun 30, 2025 $12.45M
Sga Expense Q2 2025 · Jun 30, 2024 $93.37M
Sga Expense Q2 2025 · Jun 30, 2024 $103.34M
Rd Expense Q2 2025 · Jun 30, 2025 $22.27M
Rd Expense Q2 2025 · Jun 30, 2025 $59.14M
Rd Expense Q2 2025 · Jun 30, 2024 $67.63M
Rd Expense Q2 2025 · Jun 30, 2024 $131.48M
Net Income Q2 2025 · Jun 30, 2025 −$28.65M
Net Income Q2 2025 · Jun 30, 2025 −$71.97M
Net Income Q2 2025 · Mar 31, 2025 −$43.31M
Net Income Q2 2025 · Jun 30, 2024 $1.86B
Net Income Q2 2025 · Jun 30, 2024 $1.78B
Net Income Q2 2025 · Mar 31, 2024 −$78.71M
Operating Income Q2 2025 · Jun 30, 2025 −$27.39M
Operating Income Q2 2025 · Jun 30, 2025 −$70.29M
Operating Income Q2 2025 · Jun 30, 2024 −$160.9M
Operating Income Q2 2025 · Jun 30, 2024 −$234.72M
Revenue Q2 2025 · Jun 30, 2025 $1.3M
Revenue Q2 2025 · Jun 30, 2025 $1.3M
Revenue Q2 2025 · Jun 30, 2024 $100K
Revenue Q2 2025 · Jun 30, 2024 $100K